Picture of 89bio logo

ETNB 89bio Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual balance sheet for 89bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
C2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments93.3205151188579
Prepaid Expenses
Total Other Current Assets
Total Current Assets95.3210162196594
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.1550.1660.150.4552.34
Other Long Term Assets
Total Assets95.6211162197596
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities5.618.1119.524.629.6
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities5.618.1136.54560
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity89.9203126152536
Total Liabilities & Shareholders' Equity95.6211162197596
Total Common Shares Outstanding